Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Swensen

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bone|March 14, 2003
Association of a Trp16Ser variation in the gonadotropin releasing hormone signal peptide with bone mineral density, revealed by SNP-dependent PCR typingHironori Iwasaki, Mitsuru Emi, Yoichi Ezura, et al.
Neuro-Oncology|April 4, 2017
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapyTiffany R Hodges, Martina Ott, Joanne Xiu, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum AgentsSourat Darabi, David R Braxton, Joanne Xiu, et al.
Journal of Human Genetics|January 11, 2003
Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control seriesHiromichi Fujiwara, Mitsura Emi, Hisaki Nagai, et al.
Cancers|March 25, 2022
Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene FusionsSourat Darabi, Andrew Elliott, David R Braxton, et al.
Cancer Research Communications|July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor ProfilingHassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Plos Genetics|May 20, 2016
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in CancerAnne-Mette Hartung, Jeff Swensen, Inaki E Uriz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2021
Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 studyCarlotta Antoniotti, W Michael Korn, Federica Marmorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patientsDaniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal CancerAndreas Seeber, Francesca Battaglin, Kai Zimmer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bone|March 14, 2003
Association of a Trp16Ser variation in the gonadotropin releasing hormone signal peptide with bone mineral density, revealed by SNP-dependent PCR typingHironori Iwasaki, Mitsuru Emi, Yoichi Ezura, et al.
Neuro-Oncology|April 4, 2017
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapyTiffany R Hodges, Martina Ott, Joanne Xiu, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum AgentsSourat Darabi, David R Braxton, Joanne Xiu, et al.
Journal of Human Genetics|January 11, 2003
Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control seriesHiromichi Fujiwara, Mitsura Emi, Hisaki Nagai, et al.
Cancers|March 25, 2022
Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene FusionsSourat Darabi, Andrew Elliott, David R Braxton, et al.
Cancer Research Communications|July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor ProfilingHassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Plos Genetics|May 20, 2016
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in CancerAnne-Mette Hartung, Jeff Swensen, Inaki E Uriz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2021
Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 studyCarlotta Antoniotti, W Michael Korn, Federica Marmorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patientsDaniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal CancerAndreas Seeber, Francesca Battaglin, Kai Zimmer, et al.
Pageof 2